Ret inhibitors (Bionomics/Cancer Therapeutics CRC/Walter and Eliza Hall Institute of Medical Research)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameRet inhibitors (Bionomics/Cancer Therapeutics CRC/Walter and Eliza Hall Institute of Medical Research)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTyrosine-protein kinase receptor RET inhibitors
TargetsTyrosine-protein kinase receptor RET
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New Zealand
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBionomics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCancer Therapeutics CRC Pty LtdBionomics LtdWalter And Eliza Hall Institute Of Medical Research
Active IndicationsN/A
Inactive IndicationsSolid tumours

Other Information

ATC CodeN/A
Related LinksN/A